Novel Oncology Therapies in Combination with Adjuvant Chemo in High-risk MSS-CRC

Trial Identifier:	D910CC00002
Sponsor:	MedImmune, LLC
NCTID::	NCT04145193
Start Date:	October 2020
Primary Completion Date:	March 2024
Study Completion Date:	March 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.